MYCN and neuroblastoma: Conversely, targeting MYCN with Cas9D10A was well-tolerated in MYCN non-amplified (SH-SY5Y) and MYCN non-amplified, non-neuroblastoma (HEK293T) cell lines (Fig. 2B).